| |
PROFESSIONAL EXPERIENCE
7/90-6/91
Internship, Internal Medicine, University of Alabama-Birmingham, Birmingham, AL
7/91-6/93
Residency, Internal Medicine, University of Alabama-Birmingham, Birmingham, AL
7/93-6/94
Chief Medical Resident, University of Alabama-Birmingham, Birmingham, AL
7/94-6/98
Fellow, Pulmonary Science and Critical Care Medicine, University of Colorado, Denver, CO
7/98-7/99
Instructor, Pulmonary Science and Critical Care Medicine, University of Colorado, Denver, CO
7/99-current
Assistant Professor, Pulmonary Science and Critical Care Medicine, University of Colorado, Denver, CO
AWARDS
1982 Chancellor’s Award and T.H.Harris Scholarship, Louisiana State University
1986 Graduated Cum Laude, Louisiana State University
1990 Hull-Akenhead Award, Louisiana State University School of Medicine
1991 Best Teaching Intern, University of Alabama-Birmingham
1993-1994 Chief Medical Resident, University of Alabama-Birmingham
1/00-Present Director, University Chest Clinic, University of Colorado Denver, Denver, Colorado
ORIGINAL RESEARCH
- Fontenot A, Jennings C, King TE. Pulmonary opacities and glomerulonephritis in a 15 year old boy. Chest 1998; 113: 525-527.
- Fontenot AP, Kotzin BL, Comment CE, Newman LS. Expansions of T cell subsets expressing particular T cell variable regions in chronic beryllium disease. Am. J. Respir. Cell Mol. Biol. 1998; 18: 581-589.
- Fontenot AP, Falta MT, Freed BM, Newman LS, Kotzin BL. Identification of pathogenic T cells in patients with beryllium-induced lung disease. J. Immunol. 1999; 163: 1019-1026.
- Fontenot AP, Vollmer M, Newman LS, Kotzin BL. HLA-DP restriction of CD4+ T Cells from the lungs of patients with beryllium-induced lung disease. Proc. Natl Acad Med. USA 2000; 97:12717-12722.
- Fouty B, Lynch D, Fontenot AP, Schwarz M. Hypoxemia explained 36 years later. Chest: In press.
- Fontenot AP, Newman LS, Kotzin BL. Chronic beryllium disease: recognition of a metal by HLA-DP. Clin Immunol 2001; 100: 4-14.
- Fontenot AP, Maier LA, Canavera SJ, Barker E, Boguniewicz M, Newman LS, Kotzin BL. Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung. Submitted for publication.
BOOK CHAPTERS
- Fontenot AP, King TE. Sarcoidosis: Pathogenesis. In: UpToDate (Rose BD, ed.) UpToDate. 1996.
- Fontenot AP, Kotzin BL. Immune Recognition and Responses. In: Textbook of Respiratory Medicine. Murray JF, Nadel JA, Mason RJ, Boushey HA, eds. W.B. Saunders Company. 1999: 413-441.
- Fontenot AP, Schwarz MI. Immunologic Lung Disease. In: Clinical Immunology: Practices and Principles. Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Kotzin BL, eds. Harcourt International. 2001: 84.1-84.23.
- Fontenot AP, Connelly KG. Sarcoidosis. In: Pulmonary/Respiratory Therapy Secrets (Heffner JE, Parsons PE , eds.) Hanley and Belfus, 2001:270-273.
- Fontenot AP, Schwarz MI. Diffuse Alveolar Hemorrhage. In: Interstitial Lung Disease. Schwarz MI, King TE, Jr. eds. B.C. Becker in press.
ABSTRACTS
- Fontenot AP, Newman LS, Kotzin, BL. T cell clonal expansions and marked conservation of T cell receptor sequences in the lungs of patients with chronic beryllium disease. Am.J.Respir.Crit.CareMed. 1997; 155: A983.
- Fontenot AP, Newman LS, Kotzin BL. Related T cell receptor a and b-chains in T cell clones isolated from the lungs of patients with chronic beryllium disease. WASOG September 1998. Essen, Germany.
- Fontenot AP, Newman LS, Kotzin BL. Identification of pathogenic T cells in patients with chronic beryllium disease. FASEB April 1999. Washington, D.C.
- Fontenot AP, Vollmer M, Newman L.S., Kotzin B.L.. HLA-DP restricted CD4+ T cells from the lungs of patients with chronic beryllium disease AAI May 2000. Seattle WA.
- Fontenot AP, Vollmer M, Newman L.S., Kotzin B.L. The role of HLA-DP in the presentation of beryllium to T cell in chronic beryllium disease. Thomas L. Petty Aspen Lung Conference June 2000, Aspen CO.
- Fontenot AP, Canavera SJ. Vollmer M, Newman L.S., Kotzin B.L. HLA-DP restriction of beryllium-specific CD4+ T cells bearing pathogenic T cell recpetor sequences in patients with chronic beryllium disease. Platform Presentation American Thoracic Society May 2001. San Francisco.
- Fontenot AP, Maier LA, Canavera SJ, Boguniewicz M, Newman LS, Kotzin BL. Pathologic T cells in the skin of CBD patients following beryllium patch testing. Platform Presentation 1st International WASOG June 2001. Venice, Italy.
|
